Form DEFA14A Vera Therapeutics, Inc.
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No.)
|
Filed by the Registrant
|
|
|
☒ |
|
Filed by a party other than the Registrant
|
|
|
☐ |
Check the appropriate box:
| ☐ |
Preliminary Proxy Statement
|
| ☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
| ☐ |
Definitive Proxy Statement
|
| ☒ |
Definitive Additional Materials
|
| ☐ |
Soliciting Material Pursuant to § 240.14a-12
|
|
Vera Therapeutics, Inc.
|
|
(Name of Registrant as Specified in Its Charter)
|
|
N/A
|
|
(Name of Person(s) Filing Proxy Statement if other than the Registrant)
|
Payment of Filing Fee (Check the appropriate box):
| ☒ |
No fee required
|
| ☐ |
Fee paid previously with preliminary materials
|
| ☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- A Bedding Dream Made in Heaven: Sleep Country and Sleep Number Finalize Landmark Deal to Create a $3+ Billion Global Sleep Powerhouse
- Citizens Commission on Human Rights International Announces Support for Stronger Deprescribing Safeguards and Reminds Parents of Federal Medication Protections
- Lion Copper & Gold Expands Strategic Land Position Associated with the Bear Project Area in the Yerington Copper District
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
